The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 6, pp. 775-776.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cline, J.
Right arrow Articles by Davis, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cline, J.
Right arrow Articles by Davis, S.


Research Articles

Risks of infection or reactivation of tuberculosis associated with chronic corticosteroid therapy

JC Cline and SM Davis

Although corticosteroids are known to be immunosuppressive, there have been no studies to show that use of corticosteroids increases the risk of developing new tuberculosis or reactivating old tuberculosis. In fact, corticosteroids are recommended for the treatment of several forms of tuberculosis, such as pleural tuberculosis, genitourinary tuberculosis, and tuberculous meningitis. Clinicians should still be alert for tuberculosis appearing in immunocompromised patients as a disseminated infection or for tuberculosis that is atypical in appearance.





homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.